Mineralys Therapeutics Inc.
MLYS | NASDAQ
$28.31
+$0.29 (+1.03%)
At close: Sep 21, 2026, 4:00 PM ET
$28.74
+$0.43 (+1.52%)
Pre-market:
Sep 22, 2026, 7:21 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 172.92M | 114.09M | 49.3M | 87.7M | 10.61M | 1.41M |
Short-Term Investments | 483.71M | 84.1M | 187.26M | 22.41M | n/a | n/a |
Long-Term Investments | n/a | n/a | 2.48M | n/a | n/a | n/a |
Other Long-Term Assets | 382K | 499K | 51K | 1.63M | 3K | 20K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 4.75M | 7.16M | 12.54M | 2.7M | 50K | n/a |
Total Current Assets | 661.39M | 205.35M | 249.1M | 112.81M | 11.12M | 1.47M |
Property-Plant & Equipment | 38K | 53K | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 420K | 552K | 2.53M | 1.63M | 3K | 20K |
Total Assets | 661.81M | 205.9M | 251.64M | 114.44M | 11.13M | 1.49M |
Account Payables | 2.02M | 479K | 601K | 1.91M | 763K | 529K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | 4.5M |
Other Current Liabilities | 7.56M | 3.58M | 1.6M | 665K | 313K | n/a |
Total Current Liabilities | 15.11M | 14.65M | 10.48M | 8.07M | 5.05M | 5.08M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | 158.64M | 29M | n/a |
Total Long-Term Liabilities | n/a | n/a | n/a | 158.64M | 29M | n/a |
Total Liabilities | 15.11M | 14.65M | 10.48M | 166.71M | 34.05M | 5.08M |
Total Debt | n/a | n/a | n/a | n/a | n/a | 4.5M |
Book Value | 646.69M | 191.26M | 241.15M | -52.27M | -22.93M | -3.6M |
Book Value Per Share | 9.56 | 3.94 | 6.66 | -10.12 | -4.60 | -0.78 |
Common Stock | 8K | 5K | 4K | 1K | 1K | 1K |
Retained Earnings | -457.17M | -302.52M | -124.71M | -52.81M | -23.01M | -3.6M |
Comprehensive Income | n/a | n/a | -251.64M | n/a | n/a | n/a |
Shareholders Equity | 646.69M | 191.26M | 241.15M | -52.27M | -22.93M | -3.6M |
Total Investments | 483.71M | 84.1M | 189.75M | 22.41M | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove MLYS